Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.52 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6524466 | 1.00 | GAA (0.55) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| SCHEMBL6517000 | 0.98 | GAA (0.57) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| SCHEMBL3052941 | 0.98 | GAA (0.57) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| SCHEMBL3058008 | 0.98 | GAA (0.57) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| Hydrochloric Acid SCHEMBL6527524 | 0.97 | GAA (0.55) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| Hydrochloric Acid SCHEMBL6527528 | 0.97 | GAA (0.55) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| SCHEMBL6719087 | 0.97 | EPHX1 (0.56) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| SCHEMBL6719058 | 0.95 | RECQL (0.54) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| Bromide SCHEMBL6715314 | 0.87 | GAA (0.51) | GAAL3MBTL1LMNAEPHX1TAAR1 | |
| SCHEMBL10305728 | 0.83 | RECQL (0.57) | GAAL3MBTL1LMNAEPHX1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6835841-B2 | Asymmetric catalytic hydrogenation process for preparation of chiral cyclic β-aminoesters | BRISTOL-MYERS SQUIBB COMPANY | 2004-12-28 | — | — | US | disclosed |
| US-20040082795-A1 | Asymmetric catalytic hydrogenation process for preparation of chiral cyclic beta-aminoesters | BRISTOL-MYERS SQUIBB COMPANY | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082795-A1 | Asymmetric catalytic hydrogenation process for preparation of chiral cyclic beta-aminoesters | ADAM17, ADAM9, ADAM12 | GAA 166/4885L3MBTL1 4225/4885LMNA 2168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.